(Menopause[TA])
4,860 results
  • Evolution of health-related quality of life after breast cancer surgery: longitudinal follow-up of climacteric symptoms. [Journal Article]
    Menopause. 2026 Jul 07. [Online ahead of print]Cortell-Aznar S, Ruiz-Robledillo N, … Delgado-García SM
  • CONCLUSIONS: Between 6 and 12 months after surgery, climacteric symptom burden in breast cancer survivors showed minimal change. Although statistically significant differences were observed, these remained below the MCID and are therefore unlikely to represent clinically meaningful changes. These findings support the need for early, proactive, and multidisciplinary management strategies to optimize health-related quality of life during survivorship in this population.
  • Publisher Full Text (DOI)
  • Age at natural and surgical menopause and related factors: NHANES 2013-2023. [Journal Article]
    Menopause. 2026 Jul 07. [Online ahead of print]Schulz RN, Shvartsman K, … Ahmed AEM
  • CONCLUSIONS: Differences between calculated associations and menopause timing reported in the literature are likely due to methodological and participant inclusion differences. The life table method demonstrates a similar estimate to the commonly reported value for natural menopause onset. Several modifiable factors may provide opportunities for intervention.
  • Publisher Full Text (DOI)
  • Menopause-associated pain: a decade review of patterns, determinants, and research priorities. [Journal Article]
    Menopause. 2026 Jul 07. [Online ahead of print]Ertmane E, Lulle AM
  • CONCLUSIONS: Five major pain categories were identified: musculoskeletal, urogenital, gastrointestinal, oral/orofacial, and multisite or unspecified pain. Musculoskeletal and urogenital pain were most frequently studied. Pain severity was commonly reported to peak during early menopause and declined postmenopause, although trajectories vary by pain type and comorbidity. Across domains, psychological distress, sleep disturbance, body mass index, and social determinants of health consistently modified pain perception and functional impact. Evidence for management strategies was uneven; however, exercise-based interventions demonstrated the most consistent functional benefits. Evidence for hormone therapy and complementary approaches was heterogeneous and phenotype-dependent. Although research has become more phenotype-specific and biopsychosocial in orientation, methodological heterogeneity and geographic concentration limit generalizability. Harmonized measurement, longitudinal designs, and inclusive, rigorously conducted trials are needed to support equitable, patient-centered menopause pain management.
  • Publisher Full Text (DOI)